DNA
USDGinkgo Bioworks Holdings Inc. Class A Common Stock
$11.590-0.510 (-4.215%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$12.100
High
$12.447
Low
$11.555
Volume
0.63M
Company Fundamentals
Market Cap
686.1M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.59M
Exchange
NYQ
Currency
USD
52-Week Range
Low $5Current $11.590High $17.58
Related News
PR Newswire
Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture
Ginkgo Bioworks (NYSE: DNA) today announced that the company has extended its multi-year strategic partnership with Bayer to advance research and...
View more
PR Newswire
Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program
Ginkgo Bioworks (NYSE: DNA) today announced a collaboration with STRM.BIO and the University of British Columbia (UBC) as part of the Advanced...
View more
PR Newswire
The Institute for Follicular Lymphoma Innovation (IFLI) Appoints Innovative Leaders Mehrdad Mobasher, M.D., M.P.H., and Carol O'Hear, M.D., Ph.D., as Executive Partners
The Institute for Follicular Lymphoma Innovation (IFLI), a global, non-profit, private foundation dedicated to accelerating the development of...
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.